← FDA Drug Approvals (Drugs@FDA)

ADCIRCA

NDA · New Drug Application · Sponsor: ELI LILLY CO · Approved 2009-05-22

Drug application

FDA Application #

NDA022332

Application type

New Drug Application

Brand name

ADCIRCA

Generic name

TADALAFIL

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ELI LILLY CO

Manufacturer

United Therapeutics Corporation

First approval

2009-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown